Product Background |
Kallikrein 13 (KLK13) is primarily expressed in the testis, prostate, breast, salivary glands, esophagus and the cervix and is associated with certain skin pathologies, including psoriasis vulgaris and atopic dermatitis. Moreover, KLK13 is expressed at high levels in some types of salivary gland tumors. Furthermore, it has been reported as an independent, favorable prognostic marker in breast and ovarian cancers and has potential clinical utility as a prediction marker of gastric cancer cells' response to chemotherapy. |